LXRX
Lexicon Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$1.23
+0.05 (+4.24%)
Open$1.20
Previous Close$1.18
Day High$1.27
Day Low$1.20
52W High$1.83
52W Low$0.28
Volume—
Avg Volume4.58M
Market Cap486.42M
P/E Ratio—
EPS$-0.19
SectorPharmaceuticals
Analyst Ratings
Buy
11 analysts
Price Target
+1,361.0% upside
Current
$1.23
$1.23
Target
$17.97
$17.97
$15.16
$17.97 avg
$22.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 38.40M | 68.34M | 62.90M |
| Net Income | -247,640,972 | 19.40M | 18.23M |
| Profit Margin | -644.8% | 28.4% | 29.0% |
| EBITDA | -227,749,019 | 29.54M | 28.34M |
| Free Cash Flow | — | 10.65M | 12.86M |
| Rev Growth | +369.7% | +10.7% | +9.3% |
| Debt/Equity | 0.69 | 0.92 | 0.73 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |